Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. markets closed

S&P 500
5,998.74
-22.89(-0.38%)
Dow 30
44,722.06
-138.25(-0.31%)
Nasdaq
19,060.48
-115.10(-0.60%)
Russell 2000
2,426.19
+1.88(+0.08%)
Crude Oil
68.38
-0.34(-0.49%)
Gold
2,661.80
-3.00(-0.11%)

Glenmark Pharmaceuticals Limited (GLENMARK.NS)

NSE - NSE Real Time Price. Currency in INR

Follow

1,501.10

-21.50

(-1.41%)

As of 02:03PM IST. Market open.

Previous Close	1,522.60
Open	1,524.00
Bid	1,501.10 x 0
Ask	1,501.80 x 0
Day's Range	1,496.30 - 1,533.85
52 Week Range	771.00 - 1,830.95
Volume	133,552
Avg. Volume	896,504

Market Cap	423.801B
Beta (5Y Monthly)	0.88
PE Ratio (TTM)	N/A
EPS (TTM)	-36.09
Earnings Date	Feb 13, 2025 - Feb 27, 2025
Forward Dividend & Yield	2.50 (0.16%)
Ex-Dividend Date	Sep 13, 2024
1y Target Est	1,608.07

All

Pharmaceutical Technology
Glenmark to market BeiGene’s oncology medicines in India
Glenmark will manage the necessary development, registration and distribution processes of Tislelizumab and Zanubrutinib.
Pharmaceutical Technology
Cipla and Glenmark initiate recall of certain products in the US
Cipla USA is recalling 59,244 packs of Ipratropium Bromide and Albuterol Sulfate Inhalation Solution.